Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aim Immunotech Inc (AIMID)

Aim Immunotech Inc (AIMID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aim Immunotech Inc 2117 SW HIGHWAY 484 OCALA FL 34473 USA

www.aimimmuno.com P: 352-448-7797

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.

Key Statistics

Overview:

Market Capitalization, $K 7,260
Enterprise Value, $K 5,560
Shares Outstanding, K 764
Float, K 764
% Float 99.98%
Short Volume Ratio 0.14
% of Insider Shareholders 0.02%
% of Institutional Shareholders 12.02%
Annual Net Income, $ -17,320 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -3,710 K
EBIT, $ -17,660 K
EBITDA, $ -17,060 K
3-Year Return -91.73%
5-Year Return -97.15%
5-Year Revenue Growth 21.43%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 05/15/25
Next Earnings Date 08/13/25
Earnings Per Share ttm -24.00
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 58.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 06/12/25

AIMID Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,586.23%
Return-on-Assets % -137.76%
Profit Margin % -10,188.24%
Debt/Equity 0.00
Price/Sales 30.12
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -5.36
Interest Coverage -28.36
60-Month Beta 0.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar